Mounjaro KwikPen

Mounjaro is a prescription medication containing the active ingredient tirzepatide, primarily used for the treatment of type 2 diabetes and approved in various markets for chronic weight management. The brand is synonymous with the pharmaceutical giant Eli Lilly and Company, which developed it as a first-in-class dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

The KwikPen shown in the image is a pre-filled, disposable injection device designed for ease of administration. Mounjaro's origin is firmly rooted in the United States, where Eli Lilly is headquartered. Manufacturing is conducted at several high-tech facilities across the globe, with major production hubs located in the United States, Ireland, and Germany to meet the high global demand for this therapeutic class.